Back to search

Article

Evaluating discordant somatic calls across mutation discovery approaches to minimize false negative drug-resistant findings

2023-10-30

Abstract excerpt

Evaluating robustness of somatic mutation detections is essential when utilizing whole exome sequencing (WES) for treatment decision-making. A comprehensive evaluation was conducted using tumor WES from the FDA-led Sequencing Quality Control Phase 2 (SEQC2) project, in which multiple library kits sequenced identical DNA materials across three labs to benchmark analytical validity. These workflows included various...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8048bd15-d6ff-5a42-b01c-3388b74dbdca
DOI
10.1101/2023.10.26.562640
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evaluating discordant somatic calls across mutation discovery approaches to minimize false negative drug-resistant findingsDOI 10.1101/2023.10.26.562640
Select a neighboring publication to make it the new centre.